MUSE Study to Evaluate the Pharmacokinetics, Safety and Tolerability of S6G5T-3
Clinical trial NCT04059523 · COMPLETED
Trial details
- NCT number
- NCT04059523
- Sponsor
- Sol-Gel Technologies, Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-27
- Primary completion
- 2020-02-06
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.